13 unknown. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Unknown 13 |
Follow Septic Shock: new trials by email Literature Review of Septic Shock trials Research Report on Septic Shock
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Bedtime Melatonin in Critically Ill Patients Oral Bedtime Melatonin, Placebo suspension or capsule - Septic Shock, Stroke Hemorrhagic | Phase 4 | Unknown | Hospital San Carlos, Madrid | 160 | 2025-02-01 | 2024-03-01 |
| Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock vasopressin infusion when the norepinephrine dosage is equal to or greater than 0.25 mcg/kg/min, vasopressin infusion when the norepinephrine dosage is equal to or greater than 0.5 mcg/kg/min - Septic Shock, Renal Function Replacement | Phase 4 | Unknown | Azienda Usl di Bologna | 264 | 2024-05-15 | 2024-06-24 |
| Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock Angiotensin II and hydrocortisone sodium succinate - Septic Shock, Shock | Phase 4 | Unknown | Kingman Regional Medical Center | 50 | 2023-12-04 | 2024-05-23 |
| The Construction and Application of Therapeutic System of Intelligent Decision-Oriented Hemodynamic Organized Therapy for Shock Patients norepinephrine+vasopressin, Norepinephrine - Septic Shock | Phase 4 | Unknown | Peking Union Medical College Hospital | 60 | 2023-05-01 | 2023-06-02 |
| Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality Ulinastatin - Severe Sepsis, Septic Shock | Phase 4 | Unknown | Jinnah Postgraduate Medical Centre | 175 | 2023-05-01 | 2023-06-08 |
| Low-chlorine Vs High-chlorine Crystalloids in Septic Shock Adults Sodium Bicarbonate Ringer's Injection, 0.9% Sodium Chloride Injection - Septic Shock | Phase 4 | Unknown | Southeast University, China | 100 | 2020-05-01 | 2020-04-28 |
| Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study Terlipressin, Placebo - Septic Shock | Phase 4 | Unknown | Assistance Publique Hopitaux De Marseille | 40 | 2018-07-27 | 2018-11-29 |
| Dex on Microcirculation in SS-A Double-blinded Study Dexmedetomidine for dexmedetomidine group - Septic Shock | Phase 4 | Unknown | Southeast University, China | 44 | 2016-01-01 | 2017-06-15 |
| Effects of Levosimendan, Milrinone and Norepinephrine on Left and Right Ventricular Function in Septic Shock Norepinephrine, Milrinone, Levosimendan - Septic Shock, Cardiomyopathy | Phase 4 | Unknown | Sahlgrenska University Hospital | 30 | 2015-12-01 | 2018-11-29 |
| Early Goal Directed Sedation on Microcirculation in Septic Shock Dexmedetomidine for sedation - Septic Shock | Phase 4 | Unknown | Southeast University, China | 25 | 2015-11-01 | 2016-04-20 |
| Early Continuous Renal Replacement Therapies (CRRT) in Patients With Severe Sepsis or Septic Shock With Acute Kidney Injury crrt - Severe Sepsis, Septic Shock | Phase 4 | Unknown | Asan Medical Center | 60 | 2009-02-01 | 2009-02-05 |
| Pharmacokinetic of Ceftriaxone in Septic ICU Patients ceftriaxone - Sepsis, Severe Sepsis | Phase 4 | Unknown | Association Pour La Promotion A Tours De La Reanimation Medicale | 70 | 2006-07-01 | 2007-03-21 |
| Simvastatin in Patients With Septic Shock Simvastatin - Septic Shock | Phase 4 | Unknown | Medical University of Vienna | 2007-09-17 |
Shock, Septic (13) · Sepsis (4) · Diabetes Insipidus (2) · Acute Kidney Injury (1) · Cardiomyopathies (1) · Heart Arrest (1) · Hemorrhagic Stroke (1) · Multiple Organ Failure (1) · Shock (1) · Systemic Inflammatory Response Syndrome (1) · Thrombotic Stroke (1)
Infections (13) · Inflammation (13) · Pathologic Processes (13) · Pathological Conditions, Signs and Symptoms (13) · Shock (12) · Systemic Inflammatory Response Syndrome (12) · Sepsis (9) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Cardiovascular Diseases (2) · Endocrine System Diseases (2)
Dexmedetomidine (2) · Norepinephrine (2) · Angiotensin II (1) · Capsules (1) · Ceftriaxone (1) · Continuous Renal Replacement Therapy (1) · Control Groups (1) · Drug and Narcotic Control (1) · Giapreza (1) · Hydrocortisone (1) · Melatonin (1) · Milrinone (1) · Renal Replacement Therapy (1) · Simendan (1) · Simvastatin (1)
Southeast University, China (3) · Asan Medical Center (1) · Assistance Publique Hopitaux De Marseille (1) · Association Pour La Promotion A Tours De La Reanimation Medicale (1) · Azienda Usl di Bologna (1) · Hospital San Carlos, Madrid (1) · Jinnah Postgraduate Medical Centre (1) · Kingman Regional Medical Center (1) · Medical University of Vienna (1) · Peking Union Medical College Hospital (1) · Sahlgrenska University Hospital (1)
China (3) · France (2) · Austria (1) · Italy (1) · Pakistan (1) · South Korea (1) · Sweden (1) · United States (1)
Peter Schenk, MD (1) · Sven-Erik Ricksten, Professor (1) · Tyson Dietrich, PharmD (1) · Yi Yang, Ph.D. (1) · Zeeshan Ali, FCPS (1)
PMID 21545483, PMID 24794878, PMID 36416787
2017 (1)